The companies of the groupClean Cells, Naobios & Biodextris:
a complementary service offer !

The cumulated skills and expertise of companies Clean Cells, Naobios and Biodextris are made available through their complementary service offer. The extended list of services are compliant with Good Manufacturing Practises and benefits the global biopharmaceutical industry.

In 2000, three researchers created Clean Cells, a company built around an original identification process for contaminants (mycoplasmas) in cell cultures. The assay received the innovation award from the Aventis – Institut de France foundation, and was designed to ensure that the company’s customers have, indeed, clean cells.

The Vendée-based company has always been managed with a business- and human-oriented vision and has grown consistently for the last 20 years. It offers a full service portfolio including biopharmaceutical quality control testing, cell and virus banking, storage and phage-based IMP/IND manufacturing.

Formerly known as Vivalis, then BE Vaccines, Naobios was founded in 2005 in Saint-Herblain (Nantes area). It was built around a new technology for the production of vaccines and therapeutic recombinant proteins.

Naobios also complies with the european GMP framework and has both the capabilities and the expertise to undertake the development of bioprocesses and the manufacture of cell & virus banks, preclinical and clinical lots (viral vaccines and oncolytic viruses) for the pharmaceutical industry.

Located in Laval (Quebec, Canada), Biodextris is a successful CDMO with focus on analytical and process development, including bioproduction, with over 18 years of experience with small, middle and large-sized companies. The CDMO combines its extensive expertise with the flexibility typical of smaller organizations, keeping in close touch, on project progress, with its clients. The organization has supported a wide range of clients with biopharmaceutical (vaccines, recombinant proteins, monoclonal antibodies, etc.), pharmaceutical and non-pharmaceutical products at all stages of development.

Biodextris has accumulated an extensive technical background from numerous partnerships including clinical development projects in the US, Canada, and Europe. At Biodextris, valuable experience is continuously applied, and new knowledge acquired, with every successful project ensuring clients get industry’s best practises and latest knowledge in their path toward commercialization.